Lotus Pharmaceuticals, Inc.
LTUS
$0.0053
-$0.0007-11.67%
OTC PK
09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 158.90K | 886.40K | 1.31M | 1.34M | 897.70K |
Total Receivables | 6.00M | 4.88M | 1.34M | 1.97M | 1.95M |
Inventory | 1.27M | 895.20K | 1.32M | 634.60K | 1.20M |
Prepaid Expenses | 128.40K | 137.30K | 1.15M | 577.10K | 1.03M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 400.00 | 402.60K | 167.80K | 16.70K | -- |
Total Current Assets | 7.56M | 7.20M | 5.28M | 4.54M | 5.07M |
|
|||||
Total Current Assets | 7.56M | 7.20M | 5.28M | 4.54M | 5.07M |
Net Property, Plant & Equipment | 52.28M | 47.25M | 43.09M | 39.34M | 38.99M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | 20.28M | 20.39M | 20.37M | 20.54M | 49.58M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 40.04M | 39.65M | 39.01M | 38.77M | 10.19M |
Total Assets | 120.16M | 114.49M | 107.75M | 103.18M | 103.83M |
|
|||||
Total Accounts Payable | 2.50K | 20.10K | 32.30K | 37.80K | 154.00K |
Total Accrued Expenses | 12.15M | 8.86M | 5.67M | 5.94M | 2.67M |
Short-term Debt | 769.30K | 761.90K | 749.60K | 744.90K | 735.30K |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 1.27M | 1.23M | 1.16M | 1.33M | 3.34M |
Total Other Current Liabilities | 1.27M | 1.23M | 1.16M | 1.33M | 3.34M |
Total Current Liabilities | 14.20M | 10.87M | 7.61M | 8.05M | 6.90M |
|
|||||
Total Current Liabilities | 14.20M | 10.87M | 7.61M | 8.05M | 6.90M |
Long-Term Debt | 5.41M | 5.36M | 5.28M | 5.24M | 5.17M |
Short-term Debt | 769.30K | 761.90K | 749.60K | 744.90K | 735.30K |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 1.09M | 1.01M | 936.40K | 869.10K | 864.40K |
Total Liabilities | 20.70M | 17.24M | 13.82M | 14.16M | 12.94M |
|
|||||
Common Stock & APIC | 23.84M | 23.81M | 23.81M | 21.71M | 21.08M |
Retained Earnings | 65.41M | 64.16M | 62.39M | 60.17M | 63.69M |
Treasury Stock & Other | 10.21M | 9.28M | 7.73M | 7.15M | 6.12M |
Total Common Equity | 99.45M | 97.25M | 93.93M | 89.02M | 90.89M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | 600.00 | 600.00 | 600.00 | 600.00 | 700.00 |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | 600.00 | 600.00 | 600.00 | 600.00 | 700.00 |
|
|||||
Total Common Equity | 99.45M | 97.25M | 93.93M | 89.02M | 90.89M |
Total Preferred Equity | 600.00 | 600.00 | 600.00 | 600.00 | 700.00 |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 99.45M | 97.25M | 93.93M | 89.02M | 90.89M |
|